(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia. Nikhil Lalwani ...

According to IQVIA data with a December 2024 moving annual total (MAT), the U.S. annual sales for Nitazoxanide Tablets are estimated at approximately $36.1 million. The release of this generic ...

(ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets are the generic version of the reference listed drug (RLD) Alinia®.